{
"@context": "https://schema.org",
"@type": "Article",
"headline": "FDA Clarifies Labeling Expectations for Prescription Drug Use-Related Software",
"url": "https://www.lexblog.com/2023/09/26/fda-clarifies-labeling-expectations-for-prescription-drug-use-related-software/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-Q36CGTW2",
"url": "https://www.lexblog.com/lib/Q36CGTW2/"
},
"datePublished": "2023-09-26T18:47:12-04:00",
"dateModified": "2023-09-26T15:47:56-04:00",
"author": {
"@type": "Person",
"name": "Dominick DiSabatino, Audrey Mercer"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Sheppard, Mullin, Richter & Hampton LLP"
},
"organizationScope": "at-publication",
"about": "Food, Drug & Agriculture",
"sourceUrl": "https://www.fdalawblog.com/?p=2113",
"sourceStability": "may-move"
}